share_log
Moomoo 24/7 ·  Mar 20 08:32
Puma Biotechnology Announces FDA Allowance To Proceed Under IND For Alisertib In HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment